Cap Raise shouldn't be an option if they have a successful clinical trial. They will be bought out well before then, and having natural medicinal properties with a unique physiology being sold worldwide, it won't be cheap.
Ann: NTI164 Clinical Program Update, page-12
Add NTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.3¢ |
Change
-0.002(3.08%) |
Mkt cap ! $64.09M | |||
| Open | High | Low | Value | Volume |
| 6.3¢ | 6.7¢ | 6.3¢ | $53.15K | 830.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 80079 | 6.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.5¢ | 194474 | 5 |
View Market Depth
| Last trade - 15.36pm 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
6.4¢ |
Change
-0.002 ( 3.03 %) |
||||
| Open | High | Low | Volume | ||
| 6.5¢ | 6.8¢ | 6.3¢ | 337484 | ||
| Last updated 15.27pm 04/06/2024 ? | |||||
| NTI (ASX) Chart |